Foster Robert T is CEO and Director of Hepion Pharmaceuticals, Inc.
Person profile
Roles
Hepion Pharmaceuticals
CEO and Director
Aurinia Pharmaceuticals
Director
Address
Edison, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aurinia Pharmaceuticals Inc.
22 Sep 23
3
Aurinia Pharmaceuticals Inc.
22 Sep 23
4
Hepion Pharmaceuticals, Inc.
19 Sep 23
4
Hepion Pharmaceuticals, Inc.
18 Sep 23
4
Hepion Pharmaceuticals, Inc.
20 May 21
4
Hepion Pharmaceuticals, Inc.
18 Feb 21
4
Hepion Pharmaceuticals, Inc.
8 Dec 20
4
Hepion Pharmaceuticals, Inc.
21 Aug 20
4
Hepion Pharmaceuticals, Inc.
7 Apr 20
4
Hepion Pharmaceuticals, Inc.
25 Jul 19
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Sep 23 | AUPH Aurinia Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 8.34 | 32,900 | 274.39 k | 32,900 |
| 21 Sep 23 | AUPH Aurinia Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 20,383 | 0.00 | 20,383 |
| 18 Sep 23 | HEPA Hepion Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 5.6 | 1,600 | 8.96 k | 50,470 |
| 15 Sep 23 | HEPA Hepion Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 5.4 | 1,600 | 8.64 k | 48,870 |